Target Price | $382.48 |
Price | $362.30 |
Potential | 5.57% |
Number of Estimates | 36 |
36 Analysts have issued a price target Visa 2026 . The average Visa target price is $382.48. This is 5.57% higher than the current stock price. The highest price target is $440.00 21.45% , the lowest is $305.00 15.82% . | |
A rating was issued by 43 analysts: 34 Analysts recommend Visa to buy, 9 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Visa stock has an average upside potential 2026 of 5.57% . Most analysts recommend the Visa stock at Purchase. |
35 Analysts have issued a sales forecast Visa 2025 . The average Visa sales estimate is $39.5b . This is 5.03% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $40.0b 6.32% , the lowest is $39.1b 3.80% .
This results in the following potential growth metrics:
2024 | $35.9b | 10.02% |
---|---|---|
2025 | $39.5b | 9.98% |
2026 | $43.7b | 10.48% |
2027 | $47.9b | 9.67% |
2028 | $52.5b | 9.62% |
20 Analysts have issued an Visa EBITDA forecast 2025. The average Visa EBITDA estimate is $27.9b . This is 5.51% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $28.9b 9.01% , the lowest is $27.3b 3.29% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $25.2b | 9.73% |
---|---|---|
2025 | $27.9b | 10.87% |
2026 | $30.8b | 10.35% |
2027 | $33.9b | 9.96% |
2028 | $37.1b | 9.35% |
2024 | 70.13% | 0.26% |
---|---|---|
2025 | 70.70% | 0.81% |
2026 | 70.61% | 0.13% |
2027 | 70.79% | 0.25% |
2028 | 70.62% | 0.24% |
23 Visa Analysts have issued a net profit forecast 2025. The average Visa net profit estimate is $20.9b . This is 9.57% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $22.0b 15.36% , the lowest is $20.4b 6.61% .
This results in the following potential growth metrics and future Net Margins:
2024 | $18.6b | 17.67% |
---|---|---|
2025 | $20.9b | 12.31% |
2026 | $24.6b | 17.55% |
2027 | $27.8b | 13.00% |
2028 | $31.0b | 11.42% |
2024 | 51.86% | 6.95% |
---|---|---|
2025 | 52.96% | 2.11% |
2026 | 56.35% | 6.40% |
2027 | 58.06% | 3.03% |
2028 | 59.02% | 1.65% |
23 Analysts have issued a Visa forecast for earnings per share. The average Visa EPS is $10.77 . This is 9.56% higher than earnings per share in the financial year 2024. The highest EPS forecast is $11.34 15.36% , the lowest is $10.48 6.61% .
This results in the following potential growth metrics and future valuations:
2024 | $9.59 | 17.67% |
---|---|---|
2025 | $10.77 | 12.30% |
2026 | $12.66 | 17.55% |
2027 | $14.31 | 13.03% |
2028 | $15.94 | 11.39% |
Current | 36.85 | 15.59% |
---|---|---|
2025 | 33.64 | 8.71% |
2026 | 28.62 | 14.92% |
2027 | 25.32 | 11.53% |
2028 | 22.73 | 10.23% |
Based on analysts' sales estimates for 2025, the Visa stock is valued at an EV/Sales of 17.88 and an P/S ratio of 17.78 .
This results in the following potential growth metrics and future valuations:
Current | 18.78 | 13.75% |
---|---|---|
2025 | 17.88 | 4.78% |
2026 | 16.19 | 9.49% |
2027 | 14.76 | 8.82% |
2028 | 13.46 | 8.77% |
Current | 18.67 | 13.50% |
---|---|---|
2025 | 17.78 | 4.79% |
2026 | 16.09 | 9.49% |
2027 | 14.67 | 8.82% |
2028 | 13.39 | 8.77% |
Analyst | Rating | Action | Date |
---|---|---|---|
UBS |
Buy
➜
Buy
|
Unchanged | Apr 30 2025 |
Macquarie |
Outperform
➜
Outperform
|
Unchanged | Apr 30 2025 |
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Apr 30 2025 |
BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 30 2025 |
Evercore ISI Group |
➜
In-Line
|
Initiated | Apr 09 2025 |
Susquehanna |
Positive
➜
Positive
|
Unchanged | Feb 21 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 03 2025 |
Analyst Rating | Date |
---|---|
Unchanged
UBS:
Buy
➜
Buy
|
Apr 30 2025 |
Unchanged
Macquarie:
Outperform
➜
Outperform
|
Apr 30 2025 |
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Apr 30 2025 |
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Apr 30 2025 |
Initiated
Evercore ISI Group:
➜
In-Line
|
Apr 09 2025 |
Unchanged
Susquehanna:
Positive
➜
Positive
|
Feb 21 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 03 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.